These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3262887)

  • 1. The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action.
    Gregory H; Thomas CE; Young JA; Willshire IR; Garner A
    Regul Pept; 1988 Aug; 22(3):217-26. PubMed ID: 3262887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the C-terminal dipeptide of transforming growth factor-alpha to its activity: biochemical and pharmacologic profiles.
    Yang SG; Winkler ME; Hollenberg MD
    Eur J Pharmacol; 1990 Jun; 188(6):289-300. PubMed ID: 2115447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct receptors for epidermal growth factor-urogastrone in cultured gastric smooth muscle cells.
    Yang SG; Hollenberg MD
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G827-34. PubMed ID: 2058672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo aspects of urogastrone-epidermal growth factor.
    Gregory H
    J Cell Sci Suppl; 1985; 3():11-7. PubMed ID: 3914989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of urogastrone in serum, saliva, and gastric juice.
    Gregory H; Walsh S; Hopkins CR
    Gastroenterology; 1979 Aug; 77(2):313-8. PubMed ID: 312747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.
    Bastaki SM; Chandranath SI; Singh J
    Mol Cell Biochem; 2002 Jul; 236(1-2):83-94. PubMed ID: 12190125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The primary structure of human urogastrone.
    Gregory H; Preston BM
    Int J Pept Protein Res; 1977; 9(2):107-18. PubMed ID: 300079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone.
    Twardzik DR; Sherwin SA
    J Cell Biochem; 1985; 28(4):289-97. PubMed ID: 2997242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human transforming growth factor alpha (TGF-alpha) is digested to a smaller (1-43), less biologically active, form in acidic gastric juice.
    Marchbank T; Boulton R; Hansen H; Playford RJ
    Gut; 2002 Dec; 51(6):787-92. PubMed ID: 12427777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.
    Gan BS; Hollenberg MD; MacCannell KL; Lederis K; Winkler ME; Derynck R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):331-7. PubMed ID: 3497258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.
    Yang SG; Ahmad S; Wong NC; Hollenberg MD
    Mol Pharmacol; 1994 Aug; 46(2):256-65. PubMed ID: 8078489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
    Hollenberg MD; Muramatsu I; Itoh H; Patel P; Yang SG; Lederis K
    J Pharmacol Exp Ther; 1989 Jan; 248(1):384-90. PubMed ID: 2783610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development.
    Nexø E; Hollenberg MD; Figueroa A; Pratt RM
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2782-5. PubMed ID: 6248866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity.
    Simpson RJ; Smith JA; Moritz RL; O'Hare MJ; Rudland PS; Morrison JR; Lloyd CJ; Grego B; Burgess AW; Nice EC
    Eur J Biochem; 1985 Dec; 153(3):629-37. PubMed ID: 3000782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of epidermal growth factor (beta-urogastrone) and epidermal growth factor fragments from large volumes of human urine.
    Mount CD; Lukas TJ; Orth DN
    Arch Biochem Biophys; 1985 Jul; 240(1):33-42. PubMed ID: 3874599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR; Orth DN; Stromberg K
    Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor (urogastrone)-stimulated gluconeogenesis in isolated mouse hepatocytes.
    Soley M; Hollenberg MD
    Arch Biochem Biophys; 1987 May; 255(1):136-46. PubMed ID: 3496044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.
    Hanauske AR; Buchok JB; Pardue RL; Muggia VA; Von Hoff DD
    Cancer Res; 1986 Nov; 46(11):5567-70. PubMed ID: 3463415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct coronary artery receptor systems for epidermal growth factor-urogastrone.
    Gan BS; Hollenberg MD
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1277-82. PubMed ID: 2319470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and stability of C terminal truncated human epidermal growth factor.
    Calnan DP; Fagbemi A; Berlanga-Acosta J; Marchbank T; Sizer T; Lakhoo K; Edwards AD; Playford RJ
    Gut; 2000 Nov; 47(5):622-7. PubMed ID: 11034576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.